{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:59:43Z","timestamp":1788184783971,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.575557","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T04:28:31Z","timestamp":1600835311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus"],"prefix":"10.3389","volume":"11","author":[{"given":"Masato","family":"Furuhashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukimura","family":"Higashiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Arasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/CMC.S17067","article-title":"Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases","volume":"8","author":"Furuhashi","year":"2014","journal-title":"Clin Med Insights Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5551\/jat.48710","article-title":"Fatty acid-binding protein 4 in cardiovascular and metabolic diseases","volume":"26","author":"Furuhashi","year":"2019","journal-title":"J Atheroscler Thromb."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","article-title":"Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein","volume":"274","author":"Hotamisligil","year":"1996","journal-title":"Science."},{"key":"B5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/89076","article-title":"Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis","volume":"7","author":"Makowski","year":"2001","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2","volume":"447","author":"Furuhashi","year":"2007","journal-title":"Nature."},{"key":"B7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","article-title":"Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production","volume":"17","author":"Cao","year":"2013","journal-title":"Cell Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e006377","DOI":"10.1161\/JAHA.117.006377","article-title":"Ectopic fatty acid-binding protein 4 expression in the vascular endothelium is involved in neointima formation after vascular injury","volume":"6","author":"Fuseya","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2337\/diabetes.52.2.300","article-title":"Role of the fatty acid binding protein mal1 in obesity and insulin resistance","volume":"52","author":"Maeda","year":"2003","journal-title":"Diabetes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/ATVBAHA.111.225839","article-title":"Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-gamma-regulated genes","volume":"31","author":"Babaev","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/oby.20954","article-title":"FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms","volume":"23","author":"Mita","year":"2015","journal-title":"Obesity (Silver Spring)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/ATVBAHA.116.307225","article-title":"Local production of fatty acid-binding protein 4 in epicardial\/perivascular fat and macrophages is linked to coronary atherosclerosis","volume":"36","author":"Furuhashi","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome","volume":"52","author":"Xu","year":"2006","journal-title":"Clin Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e81318","DOI":"10.1371\/journal.pone.0081318","article-title":"Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population","volume":"8","author":"Ishimura","year":"2013","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ajh.2012.88","article-title":"Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation","volume":"25","author":"Ota","year":"2012","journal-title":"Am J Hypertens."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2337\/dc07-0413","article-title":"Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort","volume":"30","author":"Tso","year":"2007","journal-title":"Diabetes Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.amjcard.2016.04.037","article-title":"Independent link between levels of proprotein convertase subtilisin\/Kexin type 9 and FABP4 in a general population without medication","volume":"118","author":"Furuhashi","year":"2016","journal-title":"Am J Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/jdi.12982","article-title":"Independent links between plasma xanthine oxidoreductase activity and levels of adipokines","volume":"10","author":"Furuhashi","year":"2019","journal-title":"J Diabetes Investig."},{"key":"B19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12933-014-0126-7","article-title":"Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population","volume":"13","author":"Fuseya","year":"2014","journal-title":"Cardiovasc Diabetol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1253\/circj.CJ-17-1295","article-title":"Circulating fatty acid-binding protein 4 concentration predicts the progression of carotid atherosclerosis in a general population without medication","volume":"82","author":"Furuhashi","year":"2018","journal-title":"Circ J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e27356","DOI":"10.1371\/journal.pone.0027356","article-title":"Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease","volume":"6","author":"Furuhashi","year":"2011","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1161\/ATVBAHA.112.248609","article-title":"Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study","volume":"32","author":"von Eynatten","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e004176","DOI":"10.1161\/JAHA.112.004176","article-title":"Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study","volume":"2","author":"Chow","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/j.atherosclerosis.2007.04.045","article-title":"Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients","volume":"195","author":"Cabre","year":"2007","journal-title":"Atherosclerosis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1194\/jlr.M059469","article-title":"Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus","volume":"56","author":"Furuhashi","year":"2015","journal-title":"J Lipid Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0154482","DOI":"10.1371\/journal.pone.0154482","article-title":"Possible increase in serum FABP4 level despite adiposity reduction by canagliflozin, an SGLT2 inhibitor","volume":"11","author":"Furuhashi","year":"2016","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12933-020-01061-0","article-title":"Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy","volume":"19","author":"Furuhashi","year":"2020","journal-title":"Cardiovasc Diabetol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-2362.2007.01835.x","article-title":"Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia","volume":"37","author":"Karpisek","year":"2007","journal-title":"Eur J Clin Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12944-016-0177-8","article-title":"Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters","volume":"15","author":"Furuhashi","year":"2016","journal-title":"Lipids Health Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/hr.2015.2","article-title":"Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension","volume":"38","author":"Furuhashi","year":"2015","journal-title":"Hypertens Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0167825","DOI":"10.1371\/journal.pone.0167825","article-title":"Transcriptome and metabolome analyses in exogenous FABP4- and FABP5-treated adipose-derived stem cells","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41598-017-00177-w","article-title":"Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages","volume":"7","author":"Furuhashi","year":"2017","journal-title":"Sci Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/eurheartj\/ehn295","article-title":"Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis","volume":"29","author":"Yeung","year":"2008","journal-title":"Eur Heart J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.amjcard.2010.06.028","article-title":"Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus","volume":"106","author":"Bagheri","year":"2010","journal-title":"Am J Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10557-018-6776-z","article-title":"Effect of anagliptin and sitagliptin on low-density lipoprotein cholesterol in type 2 diabetic patients with dyslipidemia and cardiovascular risk: rationale and study design of the REASON trial","volume":"32","author":"Ueda","year":"2018","journal-title":"Cardiovasc Drugs Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8537","DOI":"10.1038\/s41598-019-44885-x","article-title":"Randomized evaluation of anagliptin vs sitagliptin on low-density lipoproteiN cholesterol in diabetes (REASON) trial: a 52-week, open-label, randomized clinical trial","volume":"9","author":"Morimoto","year":"2019","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1073\/pnas.87.24.9590","article-title":"A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo","volume":"87","author":"Ross","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4615-4929-1_4","article-title":"Biochemical and biophysical analysis of the intracellular lipid binding proteins of adipocytes","volume":"192","author":"Simpson","year":"1999","journal-title":"Mol Cell Biochem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1172\/JCI24767","article-title":"The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation","volume":"116","author":"Shum","year":"2006","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.5665\/sleep.3210","article-title":"Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment","volume":"36","author":"Catala","year":"2013","journal-title":"Sleep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1634\/theoncologist.2016-0483","article-title":"Adipose-derived fatty acid-binding proteins plasma concentrations are increased in breast cancer patients","volume":"22","author":"Guaita-Esteruelas","year":"2017","journal-title":"Oncologist."},{"key":"B44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","article-title":"Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes","volume":"1","author":"Maeda","year":"2005","journal-title":"Cell Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2337\/db05-1496","article-title":"Regulation of metabolic responses by adipocyte\/macrophage fatty acid-binding proteins in leptin-deficient mice","volume":"55","author":"Cao","year":"2006","journal-title":"Diabetes."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/01.CIR.0000141735.13202.B6","article-title":"Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice","volume":"110","author":"Boord","year":"2004","journal-title":"Circulation."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1172\/JCI34750","article-title":"Adipocyte\/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice","volume":"118","author":"Furuhashi","year":"2008","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.575557\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T04:28:33Z","timestamp":1600835313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.575557\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":47,"alternative-id":["10.3389\/fendo.2020.575557"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.575557","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"article-number":"575557"}}